vulvar cancer – Medxy AI

Contemporary Surgical Management of Vulvar Cancer: Balancing Improved Survival with Increased Reoperation Rates — Insights from a Finnish Nationwide Study

By MedXY 09/27/2026

This review synthesizes evidence that modern personalized surgical strategies for vulvar squamous cell carcinoma enhance survival outcomes despite higher reoperation rates, emphasizing evolving surgical techniques, sentinel lymph node biopsy, and reconstructive approaches.

news OB/GYN & Women's Health Oncology

Advancing Sentinel Lymph Node Biopsy in Vulvar Cancer: Real-Time Near-Infrared Fluorescence Imaging Enhances Detection and Safety

By MedXY 09/25/2026

A recent study demonstrates the feasibility and safety of hybrid indocyanine green and technetium-99m nanoparticle fluorescence imaging for sentinel lymph node biopsy in early-stage vulvar cancer, improving detection rates and oncologic outcomes.

Clinical Updates news

Incidence, Survival, and Symptomatology of Recurrence in Vulvar Cancer: Insights from Population-Based Cohort Studies and Contemporary Evidence

By MedXY 09/11/2026

Vulvar cancer exhibits significant recurrence rates, predominantly local, with survival declining sharply after recurrence. Awareness of recurrence-associated symptoms enhances early detection. Surgery remains pivotal in management, with frailty and tumor characteristics influencing prognosis.

news OB/GYN & Women’s Health Oncology

No Time to Waste: Addressing Diagnostic Delays in Vulvar Squamous Cell Carcinoma

By MedXY 08/25/2026

This article reviews a study identifying key factors contributing to delays in diagnosing vulvar squamous cell carcinoma, emphasizing provider and system-level influences and the need for timely biopsy and specialist referrals.